These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 30522805)

  • 1. Isolation of a novel embryonic stem cell cord blood-derived population with in vitro hematopoietic capacity in the presence of Wharton's jelly-derived mesenchymal stromal cells.
    Gounari E; Daniilidis A; Tsagias N; Michopoulou A; Kouzi K; Koliakos G
    Cytotherapy; 2019 Feb; 21(2):246-259. PubMed ID: 30522805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wharton's Jelly Mesenchymal Stromal Cells Support the Expansion of Cord Blood-derived CD34
    Lo Iacono M; Russo E; Anzalone R; Baiamonte E; Alberti G; Gerbino A; Maggio A; La Rocca G; Acuto S
    Cell Transplant; 2018 Jan; 27(1):117-129. PubMed ID: 29562783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cells.
    Lee S; Park BJ; Kim JY; Jekarl D; Choi HY; Lee SY; Kim M; Kim Y; Park MS
    Cytotherapy; 2015 Dec; 17(12):1723-31. PubMed ID: 26589753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34
    Zhao D; Liu L; Chen Q; Wang F; Li Q; Zeng Q; Huang J; Luo M; Li W; Zheng Y; Liu T
    Stem Cell Res Ther; 2018 Jun; 9(1):158. PubMed ID: 29895317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.
    Milazzo L; Vulcano F; Barca A; Macioce G; Paldino E; Rossi S; Ciccarelli C; Hassan HJ; Giampaolo A
    Eur J Haematol; 2014 Nov; 93(5):384-91. PubMed ID: 24797266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.
    Ranjbaran H; Abediankenari S; Mohammadi M; Jafari N; Khalilian A; Rahmani Z; Momeninezhad Amiri M; Ebrahimi P
    Acta Med Iran; 2018 Jan; 56(1):28-33. PubMed ID: 29436792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review.
    Lo Iacono M; Anzalone R; La Rocca G; Baiamonte E; Maggio A; Acuto S
    Stem Cell Rev Rep; 2017 Feb; 13(1):35-49. PubMed ID: 27853939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
    Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
    BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.
    Li Q; Zhao D; Chen Q; Luo M; Huang J; Yang C; Wang F; Li W; Liu T
    Stem Cell Res Ther; 2019 Dec; 10(1):376. PubMed ID: 31806004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
    Liau LL; Ruszymah BHI; Ng MH; Law JX
    Curr Res Transl Med; 2020 Jan; 68(1):5-16. PubMed ID: 31543433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34(+) Transplants.
    van der Garde M; van Pel M; Millán Rivero JE; de Graaf-Dijkstra A; Slot MC; Kleinveld Y; Watt SM; Roelofs H; Zwaginga JJ
    Stem Cells Dev; 2015 Nov; 24(22):2649-59. PubMed ID: 26414086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive selection of Wharton's jelly-derived CD105(+) cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells.
    Amiri F; Halabian R; Dehgan Harati M; Bahadori M; Mehdipour A; Mohammadi Roushandeh A; Habibi Roudkenar M
    Hematology; 2015 May; 20(4):208-16. PubMed ID: 25116042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of human Wharton's jelly mesenchymal stem cells derived from different parts of the same umbilical cord.
    Bharti D; Shivakumar SB; Park JK; Ullah I; Subbarao RB; Park JS; Lee SL; Park BW; Rho GJ
    Cell Tissue Res; 2018 Apr; 372(1):51-65. PubMed ID: 29204746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture.
    Bakhshi T; Zabriskie RC; Bodie S; Kidd S; Ramin S; Paganessi LA; Gregory SA; Fung HC; Christopherson KW
    Transfusion; 2008 Dec; 48(12):2638-44. PubMed ID: 18798803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A xeno-free culture method that enhances Wharton's jelly mesenchymal stromal cell culture efficiency over traditional animal serum-supplemented cultures.
    Julavijitphong S; Wichitwiengrat S; Tirawanchai N; Ruangvutilert P; Vantanasiri C; Phermthai T
    Cytotherapy; 2014 May; 16(5):683-91. PubMed ID: 24119645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
    Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
    Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving stemness and functional features of mesenchymal stem cells from Wharton's jelly of a human umbilical cord by mimicking the native, low oxygen stem cell niche.
    Obradovic H; Krstic J; Trivanovic D; Mojsilovic S; Okic I; Kukolj T; Ilic V; Jaukovic A; Terzic M; Bugarski D
    Placenta; 2019 Jul; 82():25-34. PubMed ID: 31174623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, characterization and differentiation of mesenchymal stem cells from amniotic fluid, umbilical cord blood and Wharton's jelly in the horse.
    Iacono E; Brunori L; Pirrone A; Pagliaro PP; Ricci F; Tazzari PL; Merlo B
    Reproduction; 2012 Apr; 143(4):455-68. PubMed ID: 22274885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
    Tantrawatpan C; Manochantr S; Kheolamai P; U-Pratya Y; Supokawej A; Issaragrisil S
    J Med Assoc Thai; 2013 Sep; 96(9):1208-17. PubMed ID: 24163998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.